577 results on '"Shen, Zan"'
Search Results
2. Exploring the impact of PDGFD in osteosarcoma metastasis through single-cell sequencing analysis
3. Neoadjuvant chemotherapy-induced hemoglobin decline as a prognostic factor in osteosarcoma around the knee joint: a single-center retrospective analysis of 242 patients
4. Targeted inhibition of Wnt signaling with a Clostridioides difficile toxin B fragment suppresses breast cancer tumor growth.
5. Chemotherapy-induced nausea and vomiting among cancer patients in Shanghai: a cross-sectional study
6. Impact of particulate-matter air pollution on 25-hydroxyvitamin D levels: a mendelian randomisation study
7. ITPRIPL1 binds CD3ε to impede T cell activation and enable tumor immune evasion
8. A pilot study of multi-antigen stimulated cell therapy-I plus camrelizumab and apatinib in patients with advanced bone and soft-tissue sarcomas
9. Nanoparticle delivery of TFOs is a novel targeted therapy for HER2 amplified breast cancer
10. Combination of radiotherapy and targeted therapy for HER2-positive breast cancer brain metastases
11. A deficient MIF-CD74 signaling pathway may play an important role in immunotherapy-induced hyper-progressive disease
12. Enhancing high-content recycled asphalt pavement regeneration: A laboratory separation and treatment approach
13. BS-NAS: Broadening-and-Shrinking One-Shot NAS with Searchable Numbers of Channels
14. Chinese consensus of cardio-oncology in breast cancer
15. Correction: TRIM6 promotes colorectal cancer cells proliferation and response to thiostrepton by TIS21/FoxM1
16. New progress and prospect of breast cancer bone metastasis research from mechanism to clinic
17. D2HGDH-mediated D2HG catabolism enhances the anti-tumor activities of CAR-T cells in an immunosuppressive microenvironment
18. Safety and efficacy of fruquintinib‐based therapy in patients with advanced or metastatic sarcoma.
19. Impact of Secondary Aneurysmal Bone Cysts on Survival of Patients with Enneking Stage IIB Extremity Osteosarcoma: A Propensity Score Matching Analysis
20. Potential causal associations of PM2.5 and osteoporosis: a two-sample mendelian randomization study
21. Chromatin accessibility of CD8 T cell differentiation and metabolic regulation
22. Neiguan (PC6) acupoint stimulation for preventing chemotherapyinduced nausea and vomiting: a cost-effective supplement in guideline-inconsistent chemotherapy-induced nausea and vomiting prophylaxis subgroup.
23. Development of a monoclonal antibody to ITPRIPL1 for immunohistochemical diagnosis of non-small cell lung cancers: accuracy and correlation with CD8+ T cell infiltration
24. Impact of Particulate Matter Air Pollution on 25-Hydroxyvitamin D Levels: A Mendelian Randomization Study
25. Author Correction: Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma
26. Significance of HIFU in local unresectable recurrence of soft tissue sarcoma, a single-center, respective, case series in China
27. Influence of hematoxylin and eosin staining on linear birefringence measurement of fibrous tissue structures in polarization microscopy
28. Figure S1 from Multicenter Randomized Double-Blind Phase III Trial of Donafenib in Progressive Radioactive Iodine-Refractory Differentiated Thyroid Cancer
29. Data from Multicenter Randomized Double-Blind Phase III Trial of Donafenib in Progressive Radioactive Iodine-Refractory Differentiated Thyroid Cancer
30. Supplementary Tables 1 from Multicenter Randomized Double-Blind Phase III Trial of Donafenib in Progressive Radioactive Iodine-Refractory Differentiated Thyroid Cancer
31. Bufalin suppresses the migration and invasion of prostate cancer cells through HOTAIR, the sponge of miR-520b
32. Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma
33. TRIM6 promotes colorectal cancer cells proliferation and response to thiostrepton by TIS21/FoxM1
34. Multicenter randomized double-blind phase III trial of donafenib in progressive radioactive iodine-refractory differentiated thyroid cancer
35. Supplementary Table S5 from First-in-Maintenance Therapy for Localized High-Grade Osteosarcoma: An Open-Label Phase I/II Trial of the Anti–PD-L1 Antibody ZKAB001
36. Impact of chemotherapy cycles and intervals on outcomes of nonspinal Ewing sarcoma in adults: a real-world experience
37. H1/pHGFK1 nanoparticles exert anti-tumoural and radiosensitising effects by inhibition of MET in glioblastoma
38. Supplementary Fig. S1 from AAV-HGFK1 and Ad-p53 cocktail therapy prolongs survival of mice with colon cancer
39. Supplementary Figures 1-6 from The Kringle 1 Domain of Hepatocyte Growth Factor Has Antiangiogenic and Antitumor Cell Effects on Hepatocellular Carcinoma
40. Supplementary Figure Legends 1-6 from The Kringle 1 Domain of Hepatocyte Growth Factor Has Antiangiogenic and Antitumor Cell Effects on Hepatocellular Carcinoma
41. Anemia can predict prognosis and response to neoadjuvant chemotherapy in osteosarcoma at pre-operative stage: a retrospective analysis
42. Adherence to Analgesic Drugs and its Associated Factors among Patients with Cancer Pain: A Crosssectional Study in China
43. Optimization of drug regimen in chemotherapy based on semi-mechanistic model for myelosuppression
44. Heterogeneous expression and biological function of ubiquitin carboxy-terminal hydrolase-L1 in osteosarcoma
45. High-intensity focused ultrasound: Noninvasive treatment for local unresectable recurrence of osteosarcoma
46. First-in-Maintenance Therapy for Localized High-Grade Osteosarcoma: An Open-Label Phase I/II Trial of the Anti–PD-L1 Antibody ZKAB001
47. Donafenib in Locally Advanced/Metastatic Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trial (DIRECTION)
48. Safety and efficacy of multilevel vertebroplasty for painful osteolytic spinal metastases: a single-centre experience
49. Risk of arterial thromboembolic events with vascular endothelial growth factor receptor tyrosine kinase inhibitors: An up-to-date meta-analysis
50. Risk of gastrointestinal perforation in cancer patients treated with vascular endothelial growth factor receptor tyrosine kinase inhibitors: A systematic review and meta-analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.